Senti Biosciences, Inc. (SNTI)

USD 4.01

(-22.14%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 2.56 Million 4.28 Million 2.29 Million 394 Thousand 85 Thousand
Cost of Revenue 5.24 Million 3.92 Million 3.01 Million 15.95 Million 14.52 Million
Gross Profit -2.68 Million 366 Thousand -719 Thousand -15.56 Million -14.43 Million
Operating Expenses 94.7 Million 74.91 Million 42.73 Million 25.08 Million 7.39 Million
Selling, General and Administrative Expenses 34.86 Million 40.84 Million 21.25 Million 9.3 Million 7.34 Million
Research and Development Expenses 32.15 Million 34.06 Million 21.95 Million 15.95 Million 14.52 Million
Other Expenses 27.68 Million 12.41 Million -470 Thousand -172 Thousand -
Cost and Expenses 94.7 Million 74.91 Million 42.73 Million 25.08 Million 21.91 Million
Operating Income -92.72 Million -70.62 Million -40.44 Million -24.69 Million -21.78 Million
Interest Expense - - - - -
Income Tax Expense - -12.41 Million 11 Thousand 150 Thousand -
Earnings before Tax -83.4 Million -58.21 Million -55.31 Million -19.86 Million -21.15 Million
Net Income -92.91 Million -58.21 Million -55.31 Million -19.86 Million -21.15 Million
Earnings Per Share Basic -16.01 -22.29 -12.67 -4.55 -1.56
Earnings Per Share Diluted -16.01 -22.29 -12.67 -4.55 -1.56
Weighted Average Shares Outstanding 4.43 Million 2.61 Million 4.36 Million 4.36 Million 13.58 Million
Weighted Average Shares Outstanding (Diluted) 4.43 Million 2.61 Million 4.36 Million 4.36 Million 13.58 Million
Gross Margin -1.05 0.09 -0.31 -39.50 -169.87
EBIT Margin -23.95 -16.48 -16.33 -57.03 -251.24
Profit Margin -36.28 -13.58 -24.15 -50.41 -248.91
EBITDA -61.33 Million -70.62 Million -39.67 Million -22.7 Million -21.35 Million
Earnings Before Tax Margin -36.21 -16.48 -17.65 -62.68 -256.26

Income Statement Charts